Company / Shares Outstanding
ImmunityBio, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
852.9M
FY2025
5-year range
382.2M / 852.9M
FY2021-FY2025
Trend
+27.1%
vs FY2024
Sector context
#13 of 212
Health Care
What the data says
Among 212 Health Care companies, ImmunityBio, Inc. is in the bottom 6% for shares outstanding. Shares Outstanding has increased for 7 consecutive years, from 79021878.00 in FY2018 to 852904340.00 in FY2025.
Based on SEC 10-K filings.
852904340.00 in FY2025 with a 5-year CAGR of +54.0%. Top quartile in the Health Care sector.
Increased from 421569115.00 to 852904340.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +28.9%
- 5-Year CAGR
- +54.0%
- 10-Year CAGR
- -
Sector benchmark
+178.7% above sector average
Key checks
Key Insights
- ImmunityBio, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 27.1% year-over-year.
- Ranks #13 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 852.9M | +27.1% |
| FY2024 | 670.9M | +59.1% |
| FY2023 | 421.6M | +6.0% |
| FY2022 | 397.8M | +4.1% |
| FY2021 | 382.2M | +288.2% |
| FY2020 | 98.5M | +24.5% |
| FY2019 | 79.1M | +0.1% |
| FY2018 | 79.0M | -3.6% |
| FY2017 | 82.0M | +0.8% |
| FY2016 | 81.3M | +10100.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026